Artículo

Este artículo es de Acceso Abierto y puede ser descargado en su versión final desde nuestro repositorio
Consulte el artículo en la página del editor
Consulte la política de Acceso Abierto del editor

Abstract:

The three related 160-kDa proteins, SRC-1, TIF-2 and RAC-3, were initially identified as factors interacting with nuclear receptors. They have also been reported to potentiate the activity of other transcription factors such as AP-1 or NF-κB. The aim of this work was to identify whether SRC-1 interferes with the TGF-β/Smad signaling pathway, and if so, to identify its underlying mechanisms of action. Using transient cell transfection experiments performed in human dermal fibroblasts with the Smad3/4-specific (SBE) 4-lux reporter construct, as well as the human PAI-1 promoter, we determined that SRC-1 enhances TGF-β-induced, Smad-mediated, transcription. Likewise, SRC-1 overexpression potentiated TGF-β-induced upregulation of PAI-1 steady-state mRNA levels. Using a mammalian two-hybrid system, we demonstrated that SRC-1 interacts with the transcriptional co-activators p300/CBP, but not with Smad3. Overexpression of the adenovirus E1A oncoprotein, an inhibitor of CBP/p300 activity, prevented the enhancing effect of SRC-1 on Smad3/4-mediated transcription, indicating that p300/CBP may be required for SRC-1 effect. Such hypothesis was validated, as expression of a mutant form of SRC-1 lacking the CBP/p300-binding site failed to upregulate Smad3/4-dependent transcription, while full-length SRC-1 potentiated p300-Smad3 interactions. These results identify SRC-1 as a novel Smad3/4 transcriptional partner, facilitating the functional link between Smad3 and p300/CBP. © 2005 Nature Publishing Group All rights reserved.

Registro:

Documento: Artículo
Título:The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP
Autor:Dennler, S.; Pendaries, V.; Tacheau, C.; Costas, M.A.; Mauviel, A.; Verrecchia, F.
Filiación:INSERM U697, Institut de Recherche sur la Peau, Hôpital Saint-Louis, Paris, France
Deparmento de Cs. Biologicas, Fac. de Ciencias Exactas y Naturales, Universidad de Buenos Aires, Argentina
INSERM U697, Institut de Recherche sur la Peau, Hôpital Saint-Louis, 1, Avenue Claude Vellefaux, 75475 Paris Cedex 10, France
Palabras clave:p300; Smad; SRC-1 TGF-β; E1A protein; messenger RNA; oncoprotein; protein p300; recombinant transforming growth factor beta1; Smad protein; Smad3 protein; Smad4 protein; steroid receptor coactivator 1; virus protein; DNA binding protein; histone acetyltransferase; nuclear protein; Smad protein; steroid receptor coactivator 1; transactivator protein; transcription factor; transforming growth factor beta; Adenovirus; apoptosis; article; dermis; DNA binding; gel mobility shift assay; gene overexpression; genetic transcription; genetic transfection; human; human cell; nonhuman; Northern blotting; plasmid; priority journal; protein protein interaction; reporter gene; signal transduction; skin fibroblast; cell line; fibroblast; male; metabolism; newborn; physiology; skin; Adenoviridae; Mammalia; Cell Line; DNA-Binding Proteins; Fibroblasts; Genes, Reporter; Histone Acetyltransferases; Humans; Infant, Newborn; Male; Nuclear Proteins; Plasmids; Signal Transduction; Skin; Smad Proteins; Trans-Activators; Transcription Factors; Transcription, Genetic; Transfection; Transforming Growth Factor beta
Año:2005
Volumen:24
Número:11
Página de inicio:1936
Página de fin:1945
DOI: http://dx.doi.org/10.1038/sj.onc.1208343
Título revista:Oncogene
Título revista abreviado:Oncogene
ISSN:09509232
CODEN:ONCNE
CAS:Smad protein, 62395-38-4; Smad3 protein, 237417-78-6, 237417-96-8, 237418-00-7; Smad4 protein, 282562-18-9; histone acetyltransferase, 9054-51-7; DNA-Binding Proteins; Histone Acetyltransferases, EC 2.3.1.48; Nuclear Proteins; nuclear receptor coactivator 1, EC 2.3.1.48; Smad Proteins; Trans-Activators; Transcription Factors; Transforming Growth Factor beta
PDF:https://bibliotecadigital.exactas.uba.ar/download/paper/paper_09509232_v24_n11_p1936_Dennler.pdf
Registro:https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_09509232_v24_n11_p1936_Dennler

Referencias:

  • Andrews, N.C., Faller, D.V., (1991) Nucleic Acids Res., 19, p. 2499
  • Anzick, S.L., Kononen, J., Walker, R.L., Azorsa, D.O., Tanner, M.M., Guan, X.Y., Sauter, G., Meltzer, P.S., (1997) Science, 277, pp. 965-968
  • Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., Eckner, R., (1995) Nature, 374, pp. 81-84
  • Atfi, A., Buisine, M., Mazars, A., Gespach, C., (1997) J. Biol. Chem., 272, pp. 24731-24734
  • Attisano, L., Wrana, J.L., (2002) Science, 296, pp. 1646-1647
  • Bautista, S., Valles, H., Walker, R.L., Anzick, S., Zeillinger, R., Meltzer, P., Theillet, C., (1998) Clin. Cancer Res., 4, pp. 2925-2929
  • Berns, E.M., Van Staveren, I.L., Klijn, J.G., Foekens, J.A., (1998) Breast Cancer Res. Treat., 48, pp. 87-92
  • Bouras, T., Southey, M.C., Venter, D.J., (2001) Cancer Res., 61, pp. 903-907
  • Carrero, P., Okamoto, K., Coumailleau, P., O'Brien, S., Tanaka, H., Poellinger, L., (2000) Mol. Cell Biol., 20, pp. 402-415
  • Chauchereau, A., Georgiakaki, M., Perrin-Wolff, M., Milgrom, E., Loosfelt, H.J., (2000) J. Biol. Chem., 275, pp. 8540-8548
  • Cottone, E., Orso, F., Biglia, N., Sismondi, P., De Bortoli, M., (2001) Int. J. Biol. Markers, 16, pp. 151-166
  • DeCaestecker, M.P., Parks, W.T., Frank, C.J., Castagnino, P., Bottaro, D.P., Roberts, A.B., Lechleider, R.J., (1998) Genes Dev., 12, pp. 1587-1592
  • De Caestecker, M.P., Yahata, T., Wang, D., Parks, W.T., Huang, S., Hill, C.S., Shioda, T., Lechleider, R.J., (2000) J. Biol. Chem., 275, pp. 2115-2122
  • Dennler, S., Itoh, S., Vivien, D., Ten Dijke, P., Huet, S., Gauthier, J.M., (1998) EMBO J., 17, pp. 3091-30100
  • Derynck, R., Akhurst, R.J., Balmain, A., (2001) Nat. Genet., 29, pp. 117-129
  • Derynck, R., Zhang, Y.E., (2003) Nature, 425, pp. 577-584
  • Feng, X.H., Zhang, Y., Wu, R.Y., Derynck, R., (1998) Genes Dev., 12, pp. 2153-2163
  • Ghadimi, B.M., Schrock, E., Walker, R.L., Wangsa, D., Jauho, A., Meltzer, P.S., Ried, T., (1999) Am. J. Pathol., 154, pp. 525-536
  • Glass, C.K., Rosenfeld, M.G., (2000) Genes Dev., 14, pp. 121-141
  • Guan, X.Y., Xu, J., Anzick, S.L., Zhang, H., Trent, J.M., Meltzer, P.S., (1996) Cancer Res., 56, pp. 3446-3450
  • Janknecht, R., Wells, N.J., Hunter, T., (1998) Genes Dev., 12, pp. 2114-2119
  • Keeton, M.R., Curriden, S.A., Van Zonneveld, A.J., Loskutoff, D.J., (1991) J. Biol. Chem., 266, pp. 23048-23052
  • Kim, H.J., Kim, J.H., Lee, J.W., (1998) J. Biol. Chem., 273, pp. 28564-28567
  • Kraus, V.B., Moram, E., Neirns, J.R., (1992) Mol. Cell Biol., 12, pp. 4391-4399
  • Lee, S.K., Kim, H.J., Na, S.Y., Kim, T.S., Choi, H.S., Im, S.Y., Lee, J.W., (1998) J. Biol. Chem., 273, pp. 16651-16654
  • Lee, S.K., Kim, H.J., Kim, J.W., Lee, J.W., (1999) Mol. Endocrinol., 13, pp. 1924-1933
  • Li, H., Gomes, P.J., Chen, J.D., (1997) Proc. Natl. Acad. Sci. USA, 94, pp. 8479-8484
  • List, H.J., Reiter, R., Singh, B., Wellstein, A., Riegel, A.T., (2001) Breast Cancer Res. Treat., 68, pp. 21-28
  • Liu, F., Hata, A., Baker, J.C., Doody, J., Carcamo, J., Harland, R.M., Massague, J., (1996) Nature, 381, pp. 620-623
  • Massagué, J., Chen, Y.G., (2000) Genes Dev., 14, pp. 627-644
  • Massagué, J., Weis-Garcia, F., (1996) Cancer Surv., 27, pp. 41-64
  • McKenna, N.J., Lanz, R.B., O'Malley, B.W., (1999) Endocr. Rev., 20, pp. 321-344
  • Na, S.Y., Lee, S.K., Han, S.J., Choi, H.S., Im, S.Y., Lee, J.W., (1998) J. Biol. Chem., 273, pp. 10831-10834
  • Onate, S.A., Tsai, S.Y., Tsai, M.J., O'Malley, B.W., (1995) Science, 270, pp. 1354-1357
  • Pouponnot, C., Jayaraman, L., Massague, J., (1998) J. Biol. Chem., 273, pp. 22865-22868
  • Powell, S.M., Christiaens, V., Voulgaraki, D., Waxman, J., Claessens, F., Bevan, C.L., (2004) Endocr. Relat. Cancer, 11, pp. 117-130
  • Sakakura, C., Hagiwara, A., Yasuoka, R., Fujita, Y., Nakanishi, M., Masuda, K., Kimura, A., Yamagishi, H., (2000) Int. J. Cancer, 89, pp. 217-223
  • Shen, X., Hu, P.P., Liberati, N.T., Datto, M.B., Frederick, J.P., Wang, X.F., (1998) Mol. Biol. Cell, 9, pp. 3309-3319
  • Shi, Y., Hata, A., Lo, R.S., Massague, J., Pavletich, N.P., (1997) Nature, 388, pp. 87-93
  • Shi, Y., Massague, J., (2003) Cell, 113, pp. 685-700
  • Snowden, A.W., Perkins, N.D., (1998) Biochem. Pharmacol., 55, pp. 1947-1954
  • Topper, J.N., DiChiara, M.R., Brown, J.D., Williams, A.J., Falb, D., Collins, T., Gimbrone Jr., M.A., (1998) Proc. Natl. Acad. Sci. USA, 95, pp. 9506-9511
  • Voegel, J.J., Heine, M.J., Zechel, C., Chambon, P., Gronemeyer, H., (1996) EMBO J., 15, pp. 3667-3675
  • Wakefield, L.M., Roberts, A.B., (2002) Curr. Opin. Genet. Dev., 12, pp. 22-29
  • Workman, J.L., Kingston, R.E., (1998) Annu. Rev. Biochem., 67, pp. 545-579
  • Yanagisawa, J., Yanagi, Y., Masuhiro, Y., Suzawa, M., Watanabe, M., Kashiwagi, K., Toriyabe, T., Kato, S.C., (1999) Science, 283, pp. 1317-1321
  • Yuan, W., Condorelli, G., Caruso, M., Felsani, A., Giordano, A., (1996) J. Biol. Chem., 271, pp. 9009-9013
  • Zawel, L., Dai, J.L., Buckhaults, P., Zhou, S., Kinzler, K.W., Vogelstein, B., Kern, S.E., (1998) Mol. Cell, 1, pp. 611-617

Citas:

---------- APA ----------
Dennler, S., Pendaries, V., Tacheau, C., Costas, M.A., Mauviel, A. & Verrecchia, F. (2005) . The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP. Oncogene, 24(11), 1936-1945.
http://dx.doi.org/10.1038/sj.onc.1208343
---------- CHICAGO ----------
Dennler, S., Pendaries, V., Tacheau, C., Costas, M.A., Mauviel, A., Verrecchia, F. "The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP" . Oncogene 24, no. 11 (2005) : 1936-1945.
http://dx.doi.org/10.1038/sj.onc.1208343
---------- MLA ----------
Dennler, S., Pendaries, V., Tacheau, C., Costas, M.A., Mauviel, A., Verrecchia, F. "The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP" . Oncogene, vol. 24, no. 11, 2005, pp. 1936-1945.
http://dx.doi.org/10.1038/sj.onc.1208343
---------- VANCOUVER ----------
Dennler, S., Pendaries, V., Tacheau, C., Costas, M.A., Mauviel, A., Verrecchia, F. The steroid receptor co-activator-1 (SRC-1) potentiates TGF-β/Smad signaling: Role of p300/CBP. Oncogene. 2005;24(11):1936-1945.
http://dx.doi.org/10.1038/sj.onc.1208343